| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.86B | +37.3% |
| R&D Expense | $349.0M | -8.4% |
| SG&A Expense | $1.17B | +26.5% |
| Pre-tax Income | -$533.0M | +48.1% |
| Income Tax | $8.0M | +700.0% |
| Net Income | -$541.0M | +47.4% |
| EPS (Basic) | -$0.61 | +47.9% |
| EPS (Diluted) | -$0.61 | +47.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.83B | -23.7% |
| Current Assets | $31.79B | +38.7% |
| Total Assets | $32.33B | +38.5% |
| Current Liabilities | $25.55B | +57.2% |
| Total Liabilities | $25.64B | +56.5% |
| Stockholders' Equity | $6.70B | -3.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.18B | +238.6% |
| Investing Cash Flow | -$582.0M | -870.0% |
| Financing Cash Flow | -$610.0M | — |